lead - search results

National Institute of Justice forensic science research is strengthening the fair and impartial administration of justice, explains Jonathan McGrath, Senior Policy Analyst, National Institute of Justice, Office of Investigative and Forensic Sciences

Reforestation efforts are not ideal for natural regeneration – as one-third of forests are cut down again, after just 4 to 8 years of regeneration.

Dr Michael Wangler, Assistant Professor at Molecular and Human Genetics Baylor College of Medicine and Katie Sacra, Director of Family Programs, Global Foundation for Peroxisomal Disorders, mother of TJ, discusses the impact of the COVID-19 pandemic on families with rare disease - especially peroxisomal disorders.

Peder Vejsig Pedersen from European Green Cities turns the spotlight on energy-producing buildings and carbon zero city districts.

LGBT+ physicists face exclusionary behaviours that can lead to a change of field - with 15% of early career scientists identifying as LGBT+, what could this mean for the future?

Sabine Mai and Aline Rangel-Pozzo from CancerCare Manitoba Research Institute, The University of Manitoba, explore how 3D imaging and quantitative analysis provide key insights into genomic instability.

The experts behind QuickThink Cloud explain why public sector organisations all over the UK should be looking to host their ERP software and wider IT infrastructure in the cloud.

Professor Giovanni Brandi and Dr Simona Tavolari, explore the link between asbestos exposure and cholangiocarcinoma malignancies

Here we learn from Biljana Stangeland, PhD, Executive Director, Chief Scientific Officer and Co-founder at Alv B AS, about exciting new developments in therapeutic feline and canine cancer vaccine.

What information is available for food allergy in Africa?

Naz Dossa, CEO, Peoplesafe, explores how the Peoplesafe Alert service can enhance public safety through improved responses to terrorism.

Can single-use absorbent hygiene products gain sustainability? The answer is: Yes. Cagda Biasutti & Dr Stefanie Glathe, from Procter & Gamble explain more.

Beatrix Vereijken and Lynn Rochester share how Mobilise-D develops digital technology to measure mobility in daily life to transform clinical research and health.

Lynn Rochester is Professor of Human Movement Science in the Translational and Clinical Research Institute, Newcastle University, UK, and an NIHR Senior Investigator Her research interests are in ageing and neurodegenerative disease focused on the motor and non-motor mechanisms of gait and falls, surrogate markers of disease and disease progression,...

Beatrix Vereijken is Professor of Medicine/Human Movement Science at the Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway She was an early recipient of the Royal Dutch Academy of Sciences fellowship, and co-founder and first Head of the Department of Human Movement Science...

Dr Eric Buckland completed his Bachelor and Master of Science degree in Physics at North Carolina State University in Raleigh. He went on to receive his PhD in Optics from the University of Rochester’s Institute of Optics in New York state. Throughout his impressive career, Dr Buckland has taken...

As well as leading the Integrated Plant Protection Unit, Professor Laura Grenville-Briggs Didymus also leads her own research group, the Plant Pathology Lab. Professor Didymus' own research group focuses on the molecular and genetic determinants of disease in oomycete and fungal plant pathogens in combination with molecular analysis of interactions...

Elin Eriksen Ødegaard, Director & Professor in Early Childhood Pedagogy from Western Norway University of Applied Sciences, lifts the lid on NORCHILD, a unique research school for early childhood education & care.

Here, several academic experts explain what we need to know about removing the blindfold on antimicrobial resistance - by strengthening clinical microbiology laboratories in resource-limited settings.

Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.